Alzheimer's Disease Protocol

Cognitive & Brain HealthModerate Evidence

supplements

Primary

Supporting

Grade A

120

Studies

Primary Stack

Core supplements with strongest evidence

Omega-3 Fatty Acids (DHA)B

1-2g DHA daily

DHA is a major structural component of brain cell membranes; supports neuronal function and may reduce amyloid pathology

↑Alzheimer's Disease Symptoms

25 studies3,000 participants

Supporting Studies (2)

PMID: 25466676 - Omega-3 for Alzheimer's disease: meta-analysis (2015)PMID: 27633042 - DHA for cognitive function in Alzheimer's: systematic review (2016)

PhosphatidylserineB

100-300mg daily

Essential phospholipid for neuronal membrane function; supports neurotransmitter release and cognitive function

↑Cerebral Glucose Utilization↑Cognitive Decline

15 studies800 participants

Supporting Studies (1)

PMID: 21103034 - Phosphatidylserine for cognitive decline: meta-analysis (2010)

Supporting Stack

Additional supplements for enhanced results

Lion's Mane MushroomB

500-3000mg daily

Stimulates nerve growth factor (NGF) synthesis, promoting neurogenesis and potentially slowing cognitive decline

8 studies300 participants

Supporting Studies (1)

PMID: 19418530 - Lion's mane for mild cognitive impairment: RCT (2009)

CurcuminB

500-1000mg daily (enhanced absorption formula)

Crosses blood-brain barrier; anti-inflammatory and may inhibit amyloid plaque formation

↑Cognitive Decline↑Oxidative Stress Biomarkers

10 studies500 participants

Supporting Studies (1)

PMID: 28946614 - Curcumin for cognitive function and amyloid burden (2018)

Alpha-GPCB

300-600mg 2-3x daily

Choline source that crosses BBB; supports acetylcholine synthesis, critical for memory and learning

↑Alzheimer's Disease Symptoms↑Cognitive Decline

12 studies600 participants

Supporting Studies (1)

PMID: 12637119 - Alpha-GPC for cognitive dysfunction: RCT (2003)

Ginkgo BilobaB

120-240mg standardized extract daily

Improves cerebral blood flow, has antioxidant effects, and may modestly benefit cognitive function

Alzheimer's Disease Risk↑Cognitive Decline↑Alzheimer's Disease Symptoms↑Cognition↑Subjective Well-Being

30 studies3,000 participants

Supporting Studies (1)

PMID: 26017421 - Ginkgo biloba for dementia: Cochrane review (2015)

B Vitamins (B6, B12, Folate)B

B6 50mg, B12 500-1000mcg, Folate 400-800mcg daily

Reduce homocysteine (neurotoxic); deficiency accelerates brain atrophy and cognitive decline

Alzheimer's Disease Risk↑Alzheimer's Disease Symptoms↑Cognition↑Alzheimer's Disease Symptoms

20 studies2,000 participants

Supporting Studies (1)

PMID: 20838622 - B vitamins slow brain atrophy in MCI: RCT (2010)

How This Protocol Works

Simple Explanation

Alzheimer's disease is a progressive brain disorder characterized by memory loss, confusion, and eventually loss of ability to perform daily tasks. It involves the accumulation of amyloid plaques and tau tangles, chronic brain inflammation, and loss of neurons—particularly those using acetylcholine. While no supplement can cure Alzheimer's, some may support brain health and potentially slow decline.

IMPORTANT: These supplements are meant to complement, not replace, medical treatment. Work closely with a neurologist for Alzheimer's care.

•Omega-3 Fatty Acids (DHA) are critical for brain structure and function—DHA makes up about 40% of the fatty acids in neuronal membranes. People with higher DHA levels have lower rates of Alzheimer's. While studies in established Alzheimer's show mixed results, DHA may be more beneficial earlier in the disease process or for prevention. It has anti-inflammatory effects and may reduce amyloid accumulation.

•Phosphatidylserine is a phospholipid essential for neuronal membrane function. It supports neurotransmitter release and receptor activity. Studies show it can improve memory and cognitive function in age-related decline, with FDA-qualified health claims for cognitive function.

•Lion's Mane Mushroom is unique in that it stimulates nerve growth factor (NGF) production—a protein essential for neuron survival and function. This could theoretically support neuroplasticity and help maintain brain function. Studies in mild cognitive impairment show improved cognitive scores.

•Curcumin has potent anti-inflammatory and antioxidant properties and can cross the blood-brain barrier. Laboratory studies show it can inhibit amyloid plaque formation and reduce tau tangles. Population studies in India (where turmeric consumption is high) show lower Alzheimer's rates. Use enhanced-absorption formulas.

•Alpha-GPC is the most effective choline supplement for the brain. It crosses the blood-brain barrier and increases acetylcholine synthesis—the neurotransmitter most affected in Alzheimer's. Studies show it improves cognitive function in dementia patients.

•Ginkgo Biloba improves blood flow to the brain and has antioxidant effects. Large studies show modest benefits for cognitive function in dementia, comparable to cholinesterase inhibitors in some trials. EGb 761 is the most studied standardized extract.

•B Vitamins are essential because high homocysteine levels (common with B vitamin deficiency) are associated with faster brain atrophy and cognitive decline. Supplementation with B6, B12, and folate reduces homocysteine and significantly slows brain atrophy in people with mild cognitive impairment.

Expected timeline: Effects are gradual and aimed at slowing decline rather than reversing it. Lion's mane: 4-16 weeks. B vitamins: 8-12 weeks for homocysteine reduction. Other supplements: ongoing support over months to years.

Clinical Perspective

Alzheimer's disease is characterized by extracellular amyloid-β (Aβ) plaques, intraneuronal tau tangles, neuroinflammation, oxidative stress, cholinergic neuron loss, and progressive cerebral atrophy. Risk factors include age, genetics (APOE ε4), cardiovascular disease, diabetes, and low cognitive reserve. Current FDA-approved treatments include cholinesterase inhibitors (donepezil, rivastigmine) and memantine. This protocol targets multiple pathophysiological mechanisms.

CRITICAL: Supplements are adjunctive to standard medical care. Coordinate with neurology. Monitor for interactions with cholinesterase inhibitors and anticoagulants.

•Omega-3 (DHA) (B-grade): DHA constitutes ~40% of neuronal membrane PUFAs. Required for membrane fluidity, synaptic function, and anti-inflammatory resolvin/neuroprotectin synthesis. Neuroprotectin D1 (NPD1) from DHA is anti-apoptotic and reduces Aβ secretion. Meta-analysis: potential benefit in early stages/MCI; less clear in established AD (PMID: 25466676). Systematic review supports DHA for cognitive function (PMID: 27633042). 1-2g DHA daily; algal source for vegetarians.

•Phosphatidylserine (B-grade): Major phospholipid of inner neuronal membrane. Supports PKC signaling, neurotransmitter release (ACh, dopamine, norepinephrine), and receptor function. FDA qualified health claim for cognitive dysfunction. Meta-analysis: improvements in memory, attention in cognitive decline (PMID: 21103034). 100-300mg/day; soy-derived form well-tolerated.

•Lion's Mane (Hericium erinaceus) (B-grade): Hericenones and erinacines stimulate NGF synthesis via TrkA receptor pathway. NGF critical for cholinergic neuron survival in basal forebrain (affected early in AD). RCT in MCI: 3g/day improved cognitive function scores; effects reversed after discontinuation (PMID: 19418530). 500-3000mg/day; both fruiting body and mycelium contain active compounds.

•Curcumin (B-grade): Crosses BBB; inhibits Aβ aggregation and tau phosphorylation in vitro. Activates Nrf2 (antioxidant pathway), inhibits NF-κB (inflammation). Epidemiological: lower AD prevalence in India correlates with turmeric consumption. Small clinical trial: reduced plasma Aβ, improved cognitive function (PMID: 28946614). Bioavailability critical—use Longvida or Theracurmin formulations designed for brain penetration.

•Alpha-GPC (L-alpha-glycerylphosphorylcholine) (B-grade): Delivers choline across BBB; precursor for ACh synthesis. Cholinergic deficit is hallmark of AD. RCT: 1200mg/day improved cognitive function in mild-moderate AD comparable to acetylcholinesterase inhibitor (PMID: 12637119). May be synergistic with donepezil. 300-600mg 2-3x/day.

•Ginkgo Biloba (EGb 761) (B-grade): Contains flavonoid glycosides and terpenoids (ginkgolides, bilobalide). Improves cerebral perfusion, scavenges free radicals, modulates neurotransmitters. Cochrane review: EGb 761 at 240mg/day shows modest improvement in cognition and daily function in dementia, similar effect size to cholinesterase inhibitors (PMID: 26017421). May increase bleeding risk; coordinate with anticoagulants.

•B Vitamins (B6, B12, Folate) (B-grade): Elevated homocysteine is neurotoxic and associated with brain atrophy. B vitamins are cofactors in homocysteine metabolism. VITACOG trial: high-dose B vitamins (B6 20mg, B12 500mcg, folic acid 800mcg) slowed brain atrophy by 30% in MCI patients with elevated homocysteine; effects strongest with adequate omega-3 status (PMID: 20838622). Test homocysteine and B12 levels.

Biomarker targets: MMSE, MoCA, ADAS-Cog scores; homocysteine (<10 μmol/L); omega-3 index (>8%); B12, folate levels; MRI volumetrics if available; CSF Aβ/tau or amyloid PET if diagnostic uncertainty.

Protocol notes: Cardiovascular risk management is critical—what's good for the heart is good for the brain. Control hypertension, diabetes, hyperlipidemia. Exercise (150 min/week) may slow decline. Cognitive stimulation and social engagement are protective. Mediterranean/MIND diet pattern. Ensure adequate sleep (address sleep apnea). Manage depression and behavioral symptoms. Safety modifications for home environment. Caregiver support essential. Disease-modifying therapies (lecanemab, donanemab) are now available for early AD—discuss with neurologist. Avoid anticholinergic medications.

View All Protocols